A Review of GnRH Antagonists as Treatment for Abnormal Uterine Bleeding-Leiomyoma (AUB-L) and Their Influence on the Readiness of Service Members.

Danielle Wright, Ji Won Kim, Halle Lindsay, William H Catherino
{"title":"A Review of GnRH Antagonists as Treatment for Abnormal Uterine Bleeding-Leiomyoma (AUB-L) and Their Influence on the Readiness of Service Members.","authors":"Danielle Wright, Ji Won Kim, Halle Lindsay, William H Catherino","doi":"10.1093/milmed/usac078","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Not too long ago, Lupron Depot® (leuprolide acetate), an injectable gonadotropin-releasing hormone (GnRH) agonist, was the only Food and Drug Administration (FDA) approved GnRH analog used to clinically treat abnormal uterine bleeding associated with uterine leiomyoma (AUB-L) when second-line medical management was warranted; however, the FDA has now approved elagolix and relugolix, GnRH antagonists, to be treatment options as well. This is a review of GnRH antagonists for the management of uterine fibroids reviewing their treatment efficacy, side effect profile, and current use in military medicine.</p><p><strong>Methods: </strong>This is a review of studies from multiple electronic databases (Pubmed, ACOG, FDA, U.S. Military Guidelines) published between 1990 and 2021. Keywords used for the search include GnRH antagonist, elagolix, relugolix, uterine leiomyoma, and abnormal uterine bleeding. Our inclusion criteria for articles reviewed were: systematic reviews with the listed keywords, multicenter randomized trials, and meta-analyses. The DODI on Medical Standards for Medical Service, Air Force Aerospace Medicine Waiver Guide, Navy Guidance Aeromedical Reference and Waiver Guide, and the Army Regulation 40-501 Standards of Medical Fitness were used to review the military standards and current restrictions placed on service members.</p><p><strong>Results: </strong>Thirty-three articles were reviewed and summarized.</p><p><strong>Conclusion: </strong>Uterine leiomyoma can impact service members' eligibility and fitness for duty. The oral administration of elagolix and relugolix adds convenience to this drug class through its oral administration while lengthening the duration of treatment up to 24 months. All military medical facilities should advocate for the well-being of their service members by stocking all options available. Health care providers should collaborate with patients in making the best therapy choice that is suited for their lifestyle and military occupation.</p>","PeriodicalId":86137,"journal":{"name":"Military surgeon","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Military surgeon","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/milmed/usac078","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Not too long ago, Lupron Depot® (leuprolide acetate), an injectable gonadotropin-releasing hormone (GnRH) agonist, was the only Food and Drug Administration (FDA) approved GnRH analog used to clinically treat abnormal uterine bleeding associated with uterine leiomyoma (AUB-L) when second-line medical management was warranted; however, the FDA has now approved elagolix and relugolix, GnRH antagonists, to be treatment options as well. This is a review of GnRH antagonists for the management of uterine fibroids reviewing their treatment efficacy, side effect profile, and current use in military medicine.

Methods: This is a review of studies from multiple electronic databases (Pubmed, ACOG, FDA, U.S. Military Guidelines) published between 1990 and 2021. Keywords used for the search include GnRH antagonist, elagolix, relugolix, uterine leiomyoma, and abnormal uterine bleeding. Our inclusion criteria for articles reviewed were: systematic reviews with the listed keywords, multicenter randomized trials, and meta-analyses. The DODI on Medical Standards for Medical Service, Air Force Aerospace Medicine Waiver Guide, Navy Guidance Aeromedical Reference and Waiver Guide, and the Army Regulation 40-501 Standards of Medical Fitness were used to review the military standards and current restrictions placed on service members.

Results: Thirty-three articles were reviewed and summarized.

Conclusion: Uterine leiomyoma can impact service members' eligibility and fitness for duty. The oral administration of elagolix and relugolix adds convenience to this drug class through its oral administration while lengthening the duration of treatment up to 24 months. All military medical facilities should advocate for the well-being of their service members by stocking all options available. Health care providers should collaborate with patients in making the best therapy choice that is suited for their lifestyle and military occupation.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
GnRH拮抗剂治疗子宫异常出血-平滑肌瘤(AUB-L)及其对军人备战状态的影响
不久前,一种可注射的促性腺激素释放激素(GnRH)激动剂Lupron Depot®(醋酸leuprolide acetate)是美国食品和药物管理局(FDA)唯一批准用于临床治疗子宫平滑肌瘤(AUB-L)相关异常子宫出血的GnRH类似物。然而,FDA现在已经批准了GnRH拮抗剂elagolix和relugolix作为治疗选择。这是一篇关于GnRH拮抗剂治疗子宫肌瘤的综述,综述了它们的治疗效果、副作用和目前在军事医学中的应用。方法:这是对1990年至2021年间发表的多个电子数据库(Pubmed, ACOG, FDA, U.S. Military Guidelines)研究的综述。搜索的关键词包括GnRH拮抗剂、elagolix、relugolix、子宫平滑肌瘤、子宫异常出血。我们对文章的纳入标准是:列出关键词的系统评价、多中心随机试验和荟萃分析。根据《医疗服务医疗标准DODI》、《空军航空航天医学豁免指南》、《海军航空医学指南和豁免指南》、《陆军条例40-501医疗健康标准》,对军队标准和现役人员的现行限制进行了审查。结果对33篇文献进行了综述。结论子宫平滑肌瘤会影响现役军人的服役资格和健康。口服elagolix和relugolix通过口服给药增加了这类药物的便利性,同时延长了治疗时间,最长可达24个月。所有军事医疗设施都应通过储存所有可用的选择来倡导其服务人员的福祉。卫生保健提供者应与患者合作,做出适合其生活方式和军事职业的最佳治疗选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Race Differences in Veteran's Affairs Emergency Department Utilization. Diagnostic Accuracy of the Boston Assessment of Traumatic Brain Injury-Lifetime Clinical Interview Compared to Department of Defense Medical Records. Symptoms and Central Sensory Integration in People With Chronic mTBI: Clinical Implications. Correlates of Dietary Behaviors Among Young Emirati Males Completing Compulsory Military Service. Physiological Demands and Characteristics of Movement During Simulated Combat.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1